Adherium Limited

Adherium Limited

ADR.AX
Adherium LimitedAU flagAustralian Securities Exchange
0.01
AUD
+0.00
(-14.29%)
-0.04EPS
-0.15P/E
4.55MMarket Cap
Jul 28Next Earn
Capital Structure

in mil. unless spec.
Working Capital

in mil. unless spec.
Growth Rates

in mil. unless spec.
Quarterly Revenue

in mil. unless spec.
Quarterly Earnings Per Share

in mil. unless spec.
Quarterly Dividends Per Share

in mil. unless spec.

Company Description

CEO
Mr. Louis James Panaccio BEC, C.A., M.A.I.C.D.
Sector
Healthcare
Industry
Medical - Devices
Address
63 Albert Street Melbourne New Zealand 1010
IPO Date
Aug 26, 2015
Similar Companies
Business
Adherium Limited develops, manufactures, and supplies digital health technologies that address sub-optimal medication use in chronic diseases in New Zealand, Australia, Europe, North America, and Asia. The company offers Hailie, an asthma and chronic obstructive pulmonary disease medication adherence solution for patients with chronic respiratory diseases. It also provides Bluetooth enabled Hailie sensors, which wrap around a patient's inhalers and offers real-time feedback to patients; Hailie app; and Hailie portal. The company was incorporated in 2001 and is based in Auckland, New Zealand.